| Literature DB >> 34543119 |
Xuanxiu Ren1, Wenqi Dong1, Jiajia Feng1, Pei Li1, Yucheng Zheng1, Gaoyan Wang1, Wenjia Lu1, Xiangru Wang1,2,3, Huanchun Chen1,2,3, Chen Tan1,2,3.
Abstract
Mycobacterium tuberculosis is a chronic infectious disease pathogen. To date, tuberculosis is a major infectious disease that endangers human health. To better prevent and treat tuberculosis, it is important to study the pathogenesis of M. tuberculosis. Based on early-stage laboratory research results, in this study, we verified the upregulation of sod2 in Bacillus Calmette-Guérin (BCG) and H37Rv infection. By detecting BCG/H37Rv intracellular survival in sod2-silenced and sod2-overexpressing macrophages, sod2 was found to promote the intracellular survival of BCG/H37Rv. miR-495 then was determined to be downregulated by BCG/H37Rv. BCG/H37Rv can upregulate sod2 expression by miR-495 to promote the intracellular survival of BCG/H37Rv through a decline in ROS levels. This study provides a theoretical basis for developing new drug targets and treating tuberculosis.Entities:
Keywords: Mycobacterium tuberculosis; ROS; SOD2; intracellular survival; miR-495; microRNA
Mesh:
Substances:
Year: 2021 PMID: 34543119 PMCID: PMC8594598 DOI: 10.1128/IAI.00315-21
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441